The effect of SOX17, MACC1 and c-Met expression in ESCC on prognosis

Aim: We mainly explored the expression of SOX17, MACC1 and c-Met in esophageal squamous cell carcinoma and their influence on the prognosis of patients.Methods：Expressions of SOX17, MACC1 and c-Met protein in a sample of 232 ESCC and adjacent nontumorous tissues were detected by immunohistochemistry. Their relationships and correlations with clinicopathological features and clinical prognosis were analyzed by SPSS 23.0.Results：SOX17 was associated with Vascular invasion (p=0.017) and Nerve invasion (p=0.014). MACC1 was correlated with Tumor size (p=0.039) and TNM stage (p=0.020).c-Met was significantly associated with hematogenous metastasis (p=0.045). The expression of MACC1 was correlated with c-Met (P<0.001). c-Met expression(p=0.021) were associated with OS. Conclusion: SOX17, MACC1 and c-Met may be new diagnostic targets for esophageal squamous cell carcinoma. c-Met may be a new therapeutic and prognostic target.

[1]  S. Pothula,et al.  Targeting HGF/c-MET Axis in Pancreatic Cancer , 2020, International journal of molecular sciences.

[2]  Y. Kanki,et al.  Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development. , 2020, Seminars in cancer biology.

[3]  R. Jauch,et al.  SOX17 in cellular reprogramming and cancer. , 2020, Seminars in cancer biology.

[4]  Lixia Yang,et al.  Delivery of BR2‐SOX17 fusion protein can inhibit cell survival, proliferation, and invasion in gastric cancer cells through regulating Klotho gene expression , 2020, Cell biology international.

[5]  D. Richardson,et al.  The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents. , 2020, Biochimica et biophysica acta. General subjects.

[6]  G. Zheng,et al.  Expression of MACC1 protein in gastric cancer and its effect on proliferation and invasion of gastric cancer cells. , 2020, Cellular and molecular biology.

[7]  W. Mao,et al.  [Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database]. , 2020, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[8]  J. Marin,et al.  MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression , 2019, Hepatology.

[9]  Hui Wang,et al.  The expression and prognostic value of SOX2, β-catenin and survivin in esophageal squamous cell carcinoma. , 2019, Future oncology.

[10]  Masayuki Watanabe,et al.  Recent progress in multidisciplinary treatment for patients with esophageal cancer , 2019, Surgery Today.

[11]  H. Park,et al.  Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC) , 2019, Clinical Epigenetics.

[12]  A. Avan,et al.  The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer , 2019, IUBMB life.

[13]  Wei-Dong Chen,et al.  HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers , 2018, International journal of molecular sciences.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  Jun Li,et al.  MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma. , 2017, Oncology reports.

[16]  X. Wan,et al.  SOX17 is a tumor suppressor in endometrial cancer , 2016, Oncotarget.

[17]  R. Zeillinger,et al.  Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype , 2016, Cell adhesion & migration.

[18]  Jinlin Hu,et al.  C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome , 2016, Journal of Cancer.

[19]  H. Sasano,et al.  c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target , 2015, BMC Cancer.

[20]  H. Nakagawa,et al.  EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition , 2015, Cancer biology & therapy.

[21]  Wei Zhang,et al.  Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas. , 2014, International journal of clinical and experimental pathology.

[22]  P. Lu,et al.  Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression , 2014, International journal of cancer.

[23]  S. Jiang,et al.  Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients , 2014, International journal of medical sciences.

[24]  B. Wollenberg,et al.  Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance. , 2014, Oral oncology.

[25]  Peter M. Schlag,et al.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer , 2013, Molecular oncology.

[26]  Ming-Sound Tsao,et al.  An overview of the c-MET signaling pathway , 2011, Therapeutic advances in medical oncology.

[27]  Pei-Rong Wang,et al.  Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. , 2011, Cell stem cell.

[28]  Ruixue Yang,et al.  The expression of metastasis-associated in colon cancer-1, Snail, and KAI1 in esophageal carcinoma and their clinical significance. , 2019, International journal of clinical and experimental pathology.

[29]  Feng Yan,et al.  Overexpression of Metastasis-Associated in Colon Cancer-1 Associated with Poor Prognosis in Patients with Esophageal Cancer , 2013 .

[30]  W. Birchmeier,et al.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis , 2009, Nature Medicine.